SEC Form 4
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 |
OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response. . . . . 0.5 |
1. Name and Address of Reporting Person* Tobin, James R. (Last) (First) (Middle) One Boston Scientific Place (Street) Natick, MA 01760-1537 (City) (State) (Zip) USA |
2. Issuer Name and Ticker or Trading Symbol Boston Scientific Corporation (BSX) 3. I.R.S. Identification Number of Reporting Person, if an entity (voluntary) |
4. Statement for (Month/Day/Year) February 25, 2003 5. If Amendment, Date of Original (Month/Year) |
6. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner X Officer Other Officer/Other Description President and Chief Executive Officer 7. Individual or Joint/Group Filing (Check Applicable Line) X Individual Filing Joint/Group Filing |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
1. Title of Security (Instr. 3) |
2. Transaction Date (Month/Day/Year) |
3. Transaction Code | V |
4. Securities Acquired (A) or Disposed (D) Of Amount | A/D | Price |
5. Amount of Securities Beneficially Owned at End ofMonth (Instr. 3 and 4) |
6. Owner- ship Form: Direct(D) or Indirect (I) (Instr. 4) |
7. Nature of Indirect Beneficial Ownership (Instr. 4) |
|
|
|
|
|
|
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4(b)(v). (over) SEC 1474 (3-99) |
|
Tobin, James R. - February 2003 |
Form 4 (continued) |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) |
1. Title of Derivative Security (Instr. 3) |
2. Conver- sion or Exercise Price of Deri- vative Security |
3. Transaction Date (Month/ Day/ Year) |
4. Transaction Code and Voluntary (V) Code (Instr.8) Code | V |
5. Number of Derivative |
6. Date Exercisable(DE) and Expiration Date(ED) (Month/Day/Year) (DE) | (ED) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr.5) |
9. Number of |
10. |
11. Nature of |
Stock Option (Right to Buy) |
$43.5600 |
02/25/2003 |
A | |
(A) 100,000 |
Varies (1) | 02/25/2013 |
Common Stock - 100,000 |
|
100,000 |
D |
|
|
|
|
|
|
|
|
|
|
|
|
Explanation of Responses :
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. |
By: Lawrence J. Knopf, Attorney-in-fact ________________________________ 02-27-2003 ** Signature of Reporting Person Date Power of Attorney Page 2 SEC 1474 (3-99) |
|
Tobin, James R. - February 2003 |
Form 4 (continued) |
FOOTNOTE Descriptions for Boston Scientific Corporation (BSX) Form 4 - February 2003 James R. Tobin One Boston Scientific Place Natick, MA 01760-1537 Explanation of responses: (1) Grant to the reporting person of an option purchase 100,000 shares of common stock of the Compnay, vesting in equal annual installments beginning on February 25, 2004, 2005, 2006 and 2007, the anniversary date of the grant. |
Page 3 |